Fasciitis Complicating Subcutaneous Injection of Interferon Beta

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Subcutaneous calcification following injection of triamcinolone hexacetonide for plantar fasciitis.

Subcutaneous calcification following injection of triamcinolone hexacetonide for plantar fasciitis SIR, We report a patient who developed subcutaneous calcinosis and ulceration over the heel following injection of triamcinolone hexacetonide. This agent has the potential to cause complications many years after treatment. A 67-yr-old lady was referred with a weeping ulcer on the medial aspect of ...

متن کامل

Subcutaneous emphysema complicating asthma.

Subcutaneous emphysema complicating asthma is a somewhat rare condition and when first met with rather an alarming one. Subcutaneous emphysema as a secondary manifestation of trauma of the chest wall, fracture of the orbit with escape of air from the nasal sinuses to the neck and thorax, or on occasion complicating tracheotomy or thoracentesis, is probably more common, and the mechanism whereby...

متن کامل

COMPARE: Pharmacokinetic profiles of subcutaneous peginterferon beta‐1a and subcutaneous interferon beta‐1a over 2 weeks in healthy subjects

AIM Subcutaneous (s.c.) peginterferon beta-1a injected once every 2 weeks and s.c. interferon beta-1a injected three times per week (Rebif®) have demonstrated efficacy in relapsing-remitting multiple sclerosis, but direct comparisons of pharmacological activity and tolerability between the two products are lacking. COMPARE was an open label, crossover, pharmacokinetic (PK) study evaluating drug...

متن کامل

ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study

BACKGROUND The ExtaviJect® 30G autoinjector was developed to facilitate parenteral self-administration of interferon beta-1b (Extavia®), a first-line disease-modifying therapy in patients with multiple sclerosis. Our aim was to assess patient compliance with treatment when using the autoinjector, patients' and nurses' experiences of using the device, its tolerability, and patient satisfaction. ...

متن کامل

Skin necrosis following a recombinant interferon-beta-1b injection.

Recombinant interferon beta-1b (INF-beta-1b) has been proven to be an effective means of treating relapsing-remitting multiple sclerosis (MS). Adverse reactions to interferon therapy have been well documented. The most common side effects are transient influenza-like symptoms, including fever, fatigue, nausea, and myalgia. Cutaneous necrosis has occasionally been reported, mostly involving smal...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Canadian Journal of Gastroenterology

سال: 2000

ISSN: 0835-7900

DOI: 10.1155/2000/969163